Wiley Blackwell

SHERPA: Unknown

People

  1. Vickers
    Vickers
  2. Horwitz
    Horwitz
  3. Panageas
    Panageas
  4. Kingham
    Kingham
  5. Halpern
    Halpern
  6. Sklar
    Sklar
  7. Begg
    Begg
  8. Offit
    Offit
  9. Robson
    Robson
  10. Korc-Grodzicki
    Korc-Grodzicki

Groups

  1. Population Sciences Research Program (614)
  2. Survivorship Research (317)
  3. Department of Medicine (280)
  4. Epidemiology and Biostatistics (280)
  5. Surgery (198)
  6. Solid Tumor Oncology Division (160)
  7. Health Outcomes Research Group (138)
  8. Biostatistics Service (135)
  9. Psychiatry and Behavioral Sciences, Department of (115)
  10. Division of Subspecialty Medicine (105)
Search Within
  1. "Population Sciences Research Program"
Formats
  1. Journal Article (474)
  2. Meeting Abstract (93)
  3. Review (14)
  4. Editorial (12)
  5. Correspondence (6)
  6. Research Letter (5)
  7. Book Section (4)
  8. Conference Paper (3)
  9. Guidelines (3)
Groups
  1. Population Sciences Research Program (614)
  2. Survivorship Research (317)
  3. Department of Medicine (280)
  4. Epidemiology and Biostatistics (280)
  5. Surgery (198)
  6. Solid Tumor Oncology Division (160)

More Groups

People
  1. Andrew Vickers (69)
  2. Steven Horwitz (55)
  3. Katherine Panageas (38)
  4. T Peter Kingham (37)
  5. Allan Halpern (31)
  6. Charles Sklar (31)

More People

Years
  1. 2025 (12)
  2. 2024 (34)
  3. 2023 (38)
  4. 2022 (37)
  5. 2021 (36)
  6. 2020 (33)

More Years

Publications
  1. Cancer (240)
  2. BJU International (66)
  3. Journal of Surgical Oncology (43)
  4. Hematological Oncology (38)
  5. Journal of the American Geriatrics Society (35)
  6. Cancer Medicine (31)

More Publications

Results (614)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Plasma levels of interleukin-6 mediate neurocognitive performance in older breast cancer survivors: The Thinking and Living With Cancer study
    Journal Article

    Mandelblatt, J. S.; Small, B. J.; Zhou, X.; Nakamura, Z. M.; Cohen, H. J.; Ahles, T. A.; Ahn, J.; Bethea, T. N.; Extermann, M.; Graham, D.; more...
    Cancer (2023)

    Fulltext@MSK | Save
  • Standardized prostate cancer incidence and mortality rates following initial non-malignant biopsy result
    Journal Article

    Stroomberg, H. V.; Andersen, M. C. M.; Helgstrand, J. T.; Larsen, S. B.; Vickers, A. J.; Brasso, K.; Røder, A.
    BJU International (2023)

    Fulltext@MSK | Save
  • The BJUI editorial team's view on artificial intelligence and machine learning
    Editorial

    Thalmann, G. N.; Klatte, T.; Papa, N.; Carlsson, S. V.
    BJU International (2023)

    Fulltext@MSK | Save
  • Long term outcome of peripheral T cell lymphomas: 10y follow‐up analysis of the International Prospective T Cell Project Network
    Meeting Abstract

    Civallero, M.; Advani, R.; Horwitz, S.; Manni, M.; Cabrera, M. E.; Vose, J.; Spina, M.; Hits, F.; Nagler, A.; Montoto, S.; more...
    Hematological Oncology (2023)

    Fulltext@MSK | Save
  • Duvelisib in patients with relapsed/refractory peripheral T‐cell lymphoma from the phase 2 PRIMO Trial Expansion Phase: Outcomes by baseline histology
    Meeting Abstract

    Mehta‐Shah, N.; Jacobsen, E. D.; Zinzani, P. L.; Zain, J.; Mead, M.; Casulo, C.; Gritti, G.; Pinter‐Brown, L.; Izutsu, K.; Waters, S.; more...
    Hematological Oncology (2023)

    Fulltext@MSK | Save
  • PET‐adapted therapy with nivolumab plus adriamycin, vinblastine, and dacarbazine for newly diagnosed stage III or IV Hodgkin Lymphoma
    Meeting Abstract

    Moskowitz, A.; Savage, K.; Feldman, T.; Ganesan, N.; Hancock, H.; Davey, T.; Perez, L.; Santarosa, A.; Subzwari, S.; Capadona, C.; more...
    Hematological Oncology (2023)

    Fulltext@MSK | Save
  • Mature T and NK cell lymphomas classified according to 2016 WHO classification. A report of 741 cases registered in the International Prospective T‐cell Project 2.0
    Meeting Abstract

    Manni, M.; Chiattone, C. S.; Prince, M. H.; Pavlovsky, A.; Tomuleasa, C.; Miranda, E.; Kriachok, I.; Hawkes, E. A.; Fiad, L.; Hitz, F.; more...
    Hematological Oncology (2023)

    Fulltext@MSK | Save
  • AFM13 in patients with CD30 positive relapsed or refractory (R/R) peripheral T cell lymphoma (PTCL): Results from the phase 2 redirect study
    Meeting Abstract

    Kim, W. S.; Shortt, J.; Zinzani, P. L.; Mikhaylova, N.; Marin‐Niebla, A.; Radeski, D.; Ribrag, V.; Domenech, E. D.; Sawas, A.; Alexis, K.; more...
    Hematological Oncology (2023)

    Fulltext@MSK | Save
  • BRCA1/2 mutations impact on the development of breast implant‐associated lymphoma (BIA‐ALCL) in women with breast cancer reconstructed with textured breast implants
    Meeting Abstract

    Ghione, P.; Arcila, M.; Joseph, V.; Dogan, A.; Cordeiro, P.; Salles, G.; de Jong, D.; Horwitz, S.; Mandelker, D.; van Leeuwen, F.
    Hematological Oncology (2023)

    Fulltext@MSK | Save
  • Phase 2 trial of nivolumab plus adriamycin, vinblastine, dacarbazine (N‐AVD) as frontline therapy in older adults with Hodgkin lymphoma
    Meeting Abstract

    Torka, P.; Feldman, T.; Savage, K.; Ganesan, N.; Hancock, H.; Davey, T.; Perez, L.; Santarosa, A.; Subzwari, S.; Capadona, C.; more...
    Hematological Oncology (2023)

    Fulltext@MSK | Save